Peer review reports
From: IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
Original Submission |
6 May 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
3 Aug 2022 |
Reviewed |
Reviewer Report
|
26 Aug 2022 |
Reviewed |
Reviewer Report
|
29 Oct 2022 |
Author responded |
Author comments - Cheng Zhang
|
Resubmission - Version 4 |
29 Oct 2022 |
Submitted |
Manuscript version 4
|
1 Nov 2022 |
Author responded |
Author comments - Cheng Zhang
|
Resubmission - Version 5 |
1 Nov 2022 |
Submitted |
Manuscript version 5
|
8 Nov 2022 |
Reviewed |
Reviewer Report
|
11 Nov 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
22 Nov 2022 |
Editorially accepted |
|
3 Feb 2023 |
Article published |
10.1186/s12885-022-10353-5
|
Learn about peer review